[go: up one dir, main page]

SI2934479T1 - Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih - Google Patents

Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih

Info

Publication number
SI2934479T1
SI2934479T1 SI201331266T SI201331266T SI2934479T1 SI 2934479 T1 SI2934479 T1 SI 2934479T1 SI 201331266 T SI201331266 T SI 201331266T SI 201331266 T SI201331266 T SI 201331266T SI 2934479 T1 SI2934479 T1 SI 2934479T1
Authority
SI
Slovenia
Prior art keywords
ciclesonide
horses
treatment
airway disease
airway
Prior art date
Application number
SI201331266T
Other languages
English (en)
Inventor
Balazs Albrecht
Michael Aven
Janine Lamar
Ingo Lang
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47552829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2934479(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of SI2934479T1 publication Critical patent/SI2934479T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
SI201331266T 2012-12-21 2013-12-18 Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih SI2934479T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12199302 2012-12-21
EP13811924.3A EP2934479B1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses
PCT/EP2013/077265 WO2014096115A1 (en) 2012-12-21 2013-12-18 Ciclesonide for the treatment of airway disease in horses

Publications (1)

Publication Number Publication Date
SI2934479T1 true SI2934479T1 (sl) 2019-01-31

Family

ID=47552829

Family Applications (1)

Application Number Title Priority Date Filing Date
SI201331266T SI2934479T1 (sl) 2012-12-21 2013-12-18 Ciklezonid za zdravljenje bolezni dihalnih poti pri konjih

Country Status (24)

Country Link
US (4) US20140179651A1 (sl)
EP (1) EP2934479B1 (sl)
AR (1) AR094241A1 (sl)
AU (2) AU2013360691B2 (sl)
BR (2) BR122016029247A2 (sl)
CA (1) CA2888428C (sl)
CY (2) CY1121115T1 (sl)
DK (1) DK2934479T3 (sl)
ES (1) ES2693779T3 (sl)
FR (1) FR20C1026I1 (sl)
HR (1) HRP20181980T1 (sl)
HU (1) HUS2000020I1 (sl)
IN (1) IN2015DN02894A (sl)
LT (2) LT2934479T (sl)
MA (1) MA38169B2 (sl)
MX (1) MX368306B (sl)
NO (1) NO2020014I1 (sl)
NZ (1) NZ706573A (sl)
PL (1) PL2934479T3 (sl)
PT (1) PT2934479T (sl)
RS (1) RS57740B1 (sl)
SI (1) SI2934479T1 (sl)
WO (1) WO2014096115A1 (sl)
ZA (1) ZA201502288B (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103781468A (zh) 2011-08-12 2014-05-07 勃林格殷格翰动物保健有限公司 治疗及预防猫科动物心脏衰竭的方法中所用的起搏电流(If)抑制剂
LT2934479T (lt) 2012-12-21 2018-12-27 Boehringer Ingelheim Vetmedica Gmbh Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
IN2015DN02999A (sl) 2012-12-21 2015-09-25 Boehringer Ingelheim Vetmed
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih
WO2018070819A1 (ko) * 2016-10-14 2018-04-19 제주대학교 산학협력단 시클레소나이드를 포함하는, 암 줄기세포 성장 억제용 조성물
US20230033224A1 (en) 2020-01-10 2023-02-02 Boehringer Ingelheim Vetmedica Gmbh Ciclesonide for ameliorating quality of life (qol) in equines
MX2023001201A (es) 2020-07-31 2023-05-03 Chemo Res S L Terapia combinada para la administracion por inhalacion.

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5954049A (en) 1991-10-15 1999-09-21 Trudell Medical Limited Equine mask with MDI adapter
DE19536902A1 (de) 1995-10-04 1997-04-10 Boehringer Ingelheim Int Vorrichtung zur Hochdruckerzeugung in einem Fluid in Miniaturausführung
US5823179A (en) 1996-02-13 1998-10-20 1263152 Ontario Inc. Nebulizer apparatus and method
US6264923B1 (en) * 1998-05-13 2001-07-24 3M Innovative Properties Company Medicinal aerosol formulation of ciclesonide and related compounds
US6706726B2 (en) 2000-10-14 2004-03-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Anticholinergics which may be used as medicaments as well as processes for preparing them
DE10050994A1 (de) 2000-10-14 2002-04-18 Boehringer Ingelheim Pharma Neue als Arneimittel einsetzbare Anticholinergika sowie Verfahren zu deren Herstellung
DE10062712A1 (de) 2000-12-15 2002-06-20 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden
US6904908B2 (en) 2002-05-21 2005-06-14 Trudell Medical International Visual indicator for an aerosol medication delivery apparatus and system
DE10237739A1 (de) 2002-08-17 2004-02-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum in Kombination mit Corticosteroiden und Betamimetika
US7244742B2 (en) 2002-08-17 2007-07-17 Boehringer Ingelheim Pharma Gmbh & Co Kg Pharmaceutical compositions for inhalation containing an anticholinergic, corticosteroid and betamimetic
US20040053902A1 (en) 2002-09-13 2004-03-18 Smith C. Steven Novel composition and method for treatment of upper respiratory conditions
JP2006528228A (ja) 2003-05-22 2006-12-14 アルタナ　ファルマ　アクチエンゲゼルシャフト サルメテロール及びシクレソニドの組合せ物
US20050020692A1 (en) 2003-07-24 2005-01-27 Ciofalo Vincent B. Treatment of heaves
EP1670482B2 (en) 2003-09-16 2022-06-29 Covis Pharma B.V. Use of ciclesonide for the treatment of respiratory diseases
PE20050941A1 (es) * 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
CA2563556C (en) 2004-04-20 2013-01-29 Altana Pharma Ag Use of ciclesonide for the treatment of respiratory diseases in a smoking patient
JP2008504341A (ja) 2004-06-29 2008-02-14 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング ステロイドと抗コリン作用剤とを含む吸入用薬剤
DE102004056579A1 (de) 2004-11-23 2006-05-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Inhalative Arzneimittel enthaltend ein neues Anticholinergikum, Salmeterol und ein Steroid
UY30543A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de beta- agonistas
UY30542A1 (es) 2006-08-18 2008-03-31 Boehringer Ingelheim Int Formulacion de aerosol para la inhalacion de agonistas beta
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
US9084660B2 (en) 2009-06-25 2015-07-21 Boehringer Ingelheim Vetmedica Gmbh Inhaler
US7829748B1 (en) 2009-09-21 2010-11-09 Honeywell International Inc. Process for the manufacture of 1,3,3,3-tetrafluoropropene
EA201590030A1 (ru) 2012-07-05 2015-09-30 Арвен Айлак Санайи Ве Тиджарет А.С. Ингаляторы сухого порошка, содержащие носитель, отличный от лактозы, и третий компонент
US20150202148A1 (en) 2012-07-05 2015-07-23 Arven llac Sanayi Ve Ticaret Anonim Sirketi Dry powder inhalers comprising a carrier other than lactose
US9539408B2 (en) 2012-10-31 2017-01-10 Trudell Medical International Nebulizer apparatus
IN2015DN02999A (sl) 2012-12-21 2015-09-25 Boehringer Ingelheim Vetmed
LT2934479T (lt) 2012-12-21 2018-12-27 Boehringer Ingelheim Vetmedica Gmbh Ciklezonidas, skirtas arklių kvėpavimo takų ligų gydymui
KR102456231B1 (ko) 2013-08-20 2022-10-20 베링거잉겔하임베트메디카게엠베하 흡입기
NZ714524A (en) 2013-08-20 2020-07-31 Boehringer Ingelheim Vetmedica Gmbh Inhaler
SI3157522T1 (sl) 2014-06-18 2020-01-31 Boehringer Ingelheim Vetmedica Gmbh Muskarinski antagonisti in njihove kombinacije za zdravljenje bolezni dihalne poti pri konjih

Also Published As

Publication number Publication date
RS57740B1 (sr) 2018-12-31
BR112015010842B1 (pt) 2021-03-30
CY2020015I1 (el) 2020-11-25
MA38169A1 (fr) 2017-01-31
BR112015010842A8 (pt) 2019-10-01
AU2013360691A1 (en) 2015-04-16
BR112015010842A2 (pt) 2017-07-11
AU2018201642A1 (en) 2018-03-29
PT2934479T (pt) 2018-12-20
DK2934479T3 (en) 2018-11-05
US20170079988A1 (en) 2017-03-23
EP2934479A1 (en) 2015-10-28
US10258634B2 (en) 2019-04-16
AU2018201642B2 (en) 2019-01-31
HUS2000020I1 (hu) 2020-07-28
MA38169B2 (fr) 2021-08-31
EP2934479B1 (en) 2018-09-19
NZ706573A (en) 2019-11-29
BR122016029247A2 (pt) 2019-08-20
CY2020015I2 (el) 2021-03-12
US20150313918A1 (en) 2015-11-05
LT2934479T (lt) 2018-12-27
US10441597B2 (en) 2019-10-15
NO2020014I1 (no) 2020-06-12
AU2013360691B2 (en) 2018-03-08
MX2015007947A (es) 2015-10-08
US20180153907A1 (en) 2018-06-07
HRP20181980T1 (hr) 2019-01-25
FR20C1026I1 (fr) 2020-10-02
ZA201502288B (en) 2019-09-25
PL2934479T3 (pl) 2019-02-28
ES2693779T3 (es) 2018-12-13
US9918995B2 (en) 2018-03-20
CA2888428A1 (en) 2014-06-26
US20140179651A1 (en) 2014-06-26
CY1121115T1 (el) 2019-12-11
LTPA2020511I1 (lt) 2020-07-27
IN2015DN02894A (sl) 2015-09-11
CA2888428C (en) 2021-07-13
MX368306B (es) 2019-09-27
WO2014096115A1 (en) 2014-06-26
AR094241A1 (es) 2015-07-22

Similar Documents

Publication Publication Date Title
HUS2000020I1 (hu) Ciklezonid a légúti betegségek kezelésére lovaknál
IL263661A (en) Combination therapy for the treatment of glioblastoma
AP2014007533A0 (en) Substituted benzylindazoles for use as BUB1 kinaseinhibitors in the treatment of hyperproliferative diseases
IL239368A0 (en) Sparing–ppar thiazolidinediones and combinations for the treatment of neurodegenerative diseases of the nervous system
HK1210960A1 (en) Cyclodextrin for the treatment of lysosomal storage diseases
HK1207860A1 (en) 2-phenyl-5-heterocyclyl-tetrahydro-2h-pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders 2--5---2h--3-
PT2810599T (pt) Sistema de estimulação elétrica para o tratamento da apneia do sono
IL235058A0 (en) Pharmaceutical combinations for the treatment of metabolic disorders
HK1204452A1 (en) Treatment for bone diseases
GB201511770D0 (en) Novel pharmaceutical formulationsand their use in the treatment of periodontal disease
HK1192726A1 (en) 1,2,4-thiadiazol-5-ylpiperazine derivatives useful in the treatment of neurodegenerative diseases 124--5-
ZA201500547B (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases
HK1207593A1 (en) Medicament for treating mental and behavioural disorders
GB201002243D0 (en) Respiratory disease treatment
GB201002224D0 (en) Respiratory disease treatment
GB2515440B (en) Vesicular Formulations for use in the treatment of Rosacea
IL234796B (en) Compounds for the treatment of diseases related to ischemia-reperfusion
EP2869796A4 (en) PATIENT TREATMENT SYSTEM
EP2866555A4 (en) DOSAGE REGIME FOR THE TREATMENT OF ANIMAL
ZA201306759B (en) Compounds for use in imaging,diagnosing and/or treatment of diseases of the central nervous system
GB201002235D0 (en) Respiratory disease treatment
GB201001903D0 (en) Respiratory disease treatment
GB2477540A8 (en) Respiratory disease treatment